Pharmaids Pharmaceuticals (BOM:524572) Total Liabilities: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524572 Pharmaids Pharmaceuticals Ltd BOM:524572
23 GF Score
Price ₹31.32
! 3 Warning Signs
View Full Analysis

What is Pharmaids Pharmaceuticals Total Liabilities?

Pharmaids Pharmaceuticals BOM:524572 +1.89% 23 Total Liabilities is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:524572 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Pharmaids Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Pharmaids Pharmaceuticals's quarterly Total Liabilities increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹396.60 Mil) but then declined from Mar. 2026 (₹396.60 Mil) to Jun. 2026 (₹0.00 Mil).

Pharmaids Pharmaceuticals's annual Total Liabilities increased from Mar. 2024 (₹208.44 Mil) to Mar. 2025 (₹648.11 Mil) but then declined from Mar. 2025 (₹648.11 Mil) to Mar. 2026 (₹396.60 Mil).

Pharmaids Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Pharmaids Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaids Pharmaceuticals Total Liabilities Chart

Pharmaids Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.41 21.25 208.44 648.11 396.60

Pharmaids Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 471.28 0.00 396.60 0.00
BOM:524572
23GF Score
Pharmaids Pharmaceuticals Ltd BOM:524572
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaids Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pharmaids Pharmaceuticals's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=240.092+(136.711+19.793
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=396.6

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=872.621-476.025
=396.6

Pharmaids Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=N/A

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹0.0 Mil mean?
Pharmaids Pharmaceuticals (BOM:524572) has a Total Liabilities of ₹0.0 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Pharmaids Pharmaceuticals and its competitors.
Is Pharmaids Pharmaceuticals' Total Liabilities too high?
Pharmaids Pharmaceuticals' current Total Liabilities is ₹0.0 Mil. Overall, Pharmaids Pharmaceuticals has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Pharmaids Pharmaceuticals' Total Liabilities compare to ZTS?
Pharmaids Pharmaceuticals' Total Liabilities of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Pharmaids Pharmaceuticals and its competitors. Pharmaids Pharmaceuticals's current Total Liabilities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaids Pharmaceuticals stock overvalued right now?
Pharmaids Pharmaceuticals (BOM:524572) has a current Total Liabilities of ₹0.0 Mil. The current Total Liabilities is ₹0.0 Mil. Pharmaids Pharmaceuticals' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Pharmaids Pharmaceuticals (BOM:524572), the current Total Liabilities is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmaids Pharmaceuticals Business Description

Address HMT Factory Road, Unit 201, Brigade Rubix, 20/14, Peenya Plantation, Bangalore, KA, IND, 560013
Pharmaids Pharmaceuticals Ltd is an Indian pharmaceutical company that manufactures specialty chemicals, skin care products, hospital care products, and generic drugs. Its product range includes vitamins and related compounds, hand sanitizers, antiseptic solutions, ointments, and various bulk drugs. The company operates from Hyderabad, India, serving domestic and select international markets. Pharmaids generates revenue prominently from the sale of these pharmaceutical and healthcare products. Its operations focus on manufacturing and supplying formulations across healthcare and personal care segments.
23GF Score

Get the complete analysis for BOM:524572

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹31.32
Price